>

Avraham Fischer - CLAL BIOTECHNOLOGY Chairman of the Board

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 40px;;'>CLA</div>
  Chairman
Mr. Avraham Fischer serves as Chairman of the Board at Clal Biotechnology Industries Ltd. since September 15, 2003. Mr. Fischer currently serves as CoChief Executive Officer and Director at Clal Industries and Investments Ltd. since May 22, 2003, Executive Vice President at IDB Holdings Corporationrationration Ltd. since December 24, 2003. He serves as Director at Koor Industries Limited since July 03, 2006, IDB Development CorporationrationLtd since May 19, 2003, Hadera Paper Ltd since March 10, 2004 and Director in Other Public and Private Companies. Previously, Mr. Fischer served as Director for Vyyo Inc. from April 01, 1996 to January 07, 2009, ECI Telecom Ltd. from February 01, 2005 to October 08, 2007, Scailex Corporationration, Ltd. from June 18, 2003 to July 18, 2006, for Elbit Systems Ltd. from 2003 to July 28, 2004, Nogatech, Inc. from January 01, 1995 to October 01, 2000 and as Director for DSP Communications, Inc. from June 01, 1996 to November 01, 1999. Mr. Fischer holds an LLB in Law degree from the TelAviv University.
Age: 57  Chairman Since 2003      
972 3 612 1616  http://www.cbi.co.il

Management Efficiency

The company has return on total asset (ROA) of (5.15) % which means that it has lost $5.15 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (1.79) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 52.28 M in total debt with debt to equity ratio (D/E) of 6.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. CLAL BIOTECHNOLOGY has Current Ratio of 3.6 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Found 12 records

CHAIRMAN Since

David TsurKAMADA
2015
Leon RecanatiKAMADA
2013
Joseph SingerSOLEGREEN LTD
2019
Zeev BronfeldPROTALIX BIOTHERAP
2019
Martin GerstelEVOGENE LTD
2004
Yitzhak SultanSOLEGREEN LTD
2014
Martin GerstelCOMPUGEN
2010
Eli OpperKADIMASTEM
2010
Gal BoginSOLEGREEN LTD
2019
Shlomo YanaiPROTALIX BIOTHERAP
2014
Paul SekhriCOMPUGEN
2017
John WaymackKITOV PHARMA LTD
2019

Company Summary

Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. CLAL BIOTECHNOLOGY operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.CLAL BIOTECHNOLOGY (CBI) is traded on Tel Aviv Stock Exchange in Israel and employs 14 people.

CLAL BIOTECHNOLOGY Leadership Team

Ofer Goldberg, VPView
Sigalia Heifetz, DirectorView
Shmuel Rubinstein, External DirectorView
Tomer Babai, DirectorView
Dafna Gruber, DirectorView
Aharon Schwartz, DirectorView
Gavriel Barabash, DirectorView
Isaac Kohlberg, DirectorView
Nofar Malovani, DirectorView
Assaf Segal, CFOView
Ofer Gonen, Vice PresidentView
Avraham Fischer, Chairman of the BoardView
Yuval Yanai, External DirectorView
Julian Adams, President Chief Scientific OfficerView
Orit Lidor, VP and General CounselView

Stock Performance Indicators

Current Sentiment - CBI

CLAL BIOTECHNOLOGY Investor Sentiment

Most of Macroaxis users are currently bullish on CLAL BIOTECHNOLOGY. What is your opinion about investing in CLAL BIOTECHNOLOGY? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

CLAL BIOTECHNOLOGY Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Starwood Hotels and Alibaba Group Holding. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check out Trending Equities. Please also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page